Christopher Martell

Insider Reports History

Location
Needham, MA
Signature
/s/ Charles Schoch, as Attorney-In-Fact for Christopher Martell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Martell:

Company Role Class Num Shares Value Price $ Report Date Ownership
Candel Therapeutics, Inc. Director Common Stock 283,514 $1,363,702 $4.81 25 Jun 2025 By GTAM1 2012 ADV LLC
Candel Therapeutics, Inc. Director Common Stock 152,000 $731,120 $4.81 25 Jun 2025 By GTAM1 2012 LLC
Candel Therapeutics, Inc. Director Common Stock 111,349 $519,999 $4.67 25 Jun 2025 By Spouse
Candel Therapeutics, Inc. Director Stock Option (Right to Buy) 14,240 17 Jun 2025 Direct

Insider Reports Filed by Christopher Martell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CADL Candel Therapeutics, Inc. 25 Jun 2025 1 +$520,000 4 Director 26 Jun 2025, 08:30
CADL Candel Therapeutics, Inc. 17 Jun 2025 1 $0 4 Director 18 Jun 2025, 08:34
CADL Candel Therapeutics, Inc. 26 Jun 2024 1 $0 4 Director 27 Jun 2024, 08:39
CADL Candel Therapeutics, Inc. 28 Jun 2023 1 $0 4 Director 29 Jun 2023, 09:00
CADL Candel Therapeutics, Inc. 08 Dec 2022 2 +$51,108 4/A Director 17 Feb 2023, 17:40
CADL Candel Therapeutics, Inc. 13 Oct 2022 1 $0 4 Director 17 Oct 2022, 16:42
CADL Candel Therapeutics, Inc. 29 Jul 2021 3 +$1,000,000 4 Director 02 Aug 2021, 20:12
CADL Candel Therapeutics, Inc. 26 Jul 2021 0 $0 3 Director 26 Jul 2021, 21:20